Martin Shkreli Faces Legal Scrutiny for Breaking Industry Ban
WHO:
CNN - Martin Shkreli, known as "Pharma Bro"
CNN - Federal Trade Commission (FTC)
CNN - Attorneys general from seven states: New York, California, Illinois, North Carolina, Ohio, Pennsylvania, and Virginia
WHAT:
CNN - Shkreli launched a trading competition with an account boasting a $10 million balance.
CNN - Authorities allege Shkreli has set up a trading competition involving at least 11 pharmaceutical stocks.
CNN - Shkreli has been shorting stocks, including betting against Cassava Sciences, and publicly commented on the company's clinical study.
CNN - Shkreli claimed, “I can always find a couple of biotech stocks to smoke,” during a livestream.
CNN - Shkreli stated, “I don’t think it doesn’t work. It is impossible for it to work,” regarding Cassava Sciences on November 21, 2024.
CNN - Four days after Shkreli's statement, Cassava publicly said the clinical study failed.
CNN - Authorities are seeking to hold Shkreli in contempt and potentially imprison him if he does not cease his trading activities.
CNN - The FTC and states allege that Shkreli has set up a trading competition involving at least 11 pharmaceutical stocks since his release from prison.
CNN - Shkreli has publicly stated, “I can always find a couple of biotech stocks to smoke,” during a livestream.
CNN - The FTC and states are seeking to hold Shkreli in contempt and fine him for the total profits he made from his trades.
CNN - Authorities allege Shkreli has set up a trading competition involving at least 11 pharmaceutical stocks.
CNN - Shkreli has publicly stated, “I have some other accounts that I’[d] show you, but, like, I know feds are watching, so f*ck that.”
CNN - Shkreli claimed, “They don’t want you to know. They want you to stay stupid. I try to give you some advice. Twenty years of experience. I made a lot of money in these binary events, man. Some people say that I’m the GOAT at it, but you didn’t want to hear nothing.”
CNN - Authorities allege Shkreli’s sister and her partner appear to have assisted him in his trading activities.
CNN - Shkreli has been accused of violating a court order that barred him from participating in the pharmaceutical industry.
CNN - The FTC and seven states filed a contempt claim against Shkreli, seeking to hold him in contempt, fine him for his profits, and potentially imprison him.
CNN - Shkreli launched a trading competition with a $10 million balance and has been livestreaming his stock trades.
CNN - Shkreli was found liable in a 2020 lawsuit for raising the price of Daraprim by 4,000% to $750 per pill, resulting in a $64.6 million penalty and a lifetime ban from the pharmaceutical industry.
WHERE:
CNN - The legal actions involve federal and state authorities in the United States.
WHEN:
CNN - Shkreli was released from prison in May 2022 after serving time for securities fraud.
CNN - The FTC and states filed a lawsuit against Shkreli in 2020.
CNN - Shkreli made a statement on November 21, 2024, regarding the clinical study of Cassava Sciences.
WHY:
CNN - The authorities claim that Shkreli's actions may represent only the "tip of the iceberg" regarding his misconduct in the pharmaceutical industry.
CNN - The FTC and states claim that what they uncovered may be the “tip of the iceberg” regarding Shkreli's misconduct.
CNN - The authorities allege that Shkreli has "flagrantly and repeatedly" violated the court order due to his trading activities and public statements.
HOW:
CNN - Authorities allege Shkreli’s sister and her partner appear to have assisted him in his trading activities.
CNN - Shkreli has indicated that he conducts most of his trading off social media, suggesting he has additional undisclosed accounts.
CNN - Shkreli has been livestreaming his stock trades on YouTube and has indicated he has additional trading accounts not disclosed on social media.
CNN - He has been shorting stocks, including betting against Cassava Sciences, and publicly commented on the company's clinical study.
(UPDATED October 14, 2026 04:05 UTC)
In a bold move, Martin Shkreli has launched a trading competition featuring an impressive $10 million account, focusing on at least eleven pharmaceutical stocks. Authorities allege that Shkreli has been shorting stocks, including betting against Cassava Sciences, and he made a controversial statement during a livestream, claiming, “I can always find a couple of biotech stocks to smoke.” Additionally, it's reported that Shkreli's sister and her partner may have assisted him in these trading activities.
--
(UPDATED October 14, 2026 01:21 UTC)
Authorities are seeking to hold Trump in contempt and potentially imprison him if he does not cease his trading activities, as the FTC and several states allege he has set up a trading competition involving at least eleven pharmaceutical stocks since his release from prison. During a recent livestream, Trump publicly stated, “I can always find a couple of biotech stocks to smoke,” which has raised concerns that his actions may represent only the "tip of the iceberg" regarding his misconduct in the pharmaceutical industry. Additionally, Trump has indicated that he conducts most of his trading off social media, suggesting he may have additional undisclosed accounts.
--
(UPDATED October 14, 2026 00:01 UTC)
The FTC and several states are taking action to hold Shkreli in contempt and impose fines for the profits he made from his trading activities, which allegedly include a competition involving at least eleven pharmaceutical stocks. Authorities also claim that Shkreli's sister and her partner may have assisted him in these endeavors, while Shkreli himself has made provocative statements about his trading strategies and the scrutiny he faces. The FTC and states suggest that their findings could be just the “tip of the iceberg” when it comes to uncovering Shkreli's misconduct.
--
(UPDATED October 13, 2026 19:08 UTC)
Martin Shkreli, known as "Pharma Bro," is facing a contempt claim from the Federal Trade Commission and attorneys general from seven states, including New York and California, for allegedly violating a court order that prohibits him from participating in the pharmaceutical industry. The authorities accuse Shkreli of "flagrantly and repeatedly" breaching this order through his recent trading activities, which include livestreaming stock trades and shorting stocks like Cassava Sciences. Shkreli, who was released from prison in May 2022 after serving time for securities fraud, previously faced a $64.6 million penalty and a lifetime ban from the pharmaceutical sector for dramatically increasing the price of Daraprim.